Since the first, seminal randomised controlled trial (RCT) in inflammatory bowel disease (IBD) in 1955,1 the central tenets for high-quality clinical trials have been recognised as robust and ...

A recent study showed that working-age patients with post-acute sequelae of COVID-19/post-COVID-19 syndrome do not recover in the second year of their illness.

ACUTE rheumatic fever, in the absence of intercurrent streptococcal respiratory infections and rheumatic recrudescences, is generally a self-limited disease that subsides within twelve weeks.

Patient has been under dermatology follow-up, using topical medications, and submitted to salicylic acid peeling at 30%, without intercurrent events. Despite the intense adverse reaction, patient ...